PATENT CLAIM ANALYSIS

Application Number: 15994571
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-10
Patent Classification: ["424", "125000"]

Abstract:
The present disclosure describes methods and compositions for the treatment of neurological disorders and related symptoms by the in vivo sequestration and excretion of microbial metabolites. These metabolites are related to neurological disorders such as autism and Parkinson's disease, as well as intestinal hyperpermeability (leaky gut) and gastrointestinal comorbidities associated with such disorders.

Claim (Index 13):
The method of  claim 1 , wherein the method is repeated as necessary to maintain reduced levels of intestinal metabolites relative to levels identified prior to first administration of the sequestrant composition.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 93.0
- Lexical Diversity: 1.34091
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14012769', '14925510', '13267748', '14866791', '15004218']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6506504149422131
- 35 USC 102 Novelty (BERT): 0.5235237259843414
- Combined Prediction Score: 0.637937746046426
- Mean Citation Score: 184.843678
- Max Citation Score: 247.5951
- Similarity Product: 130.73703020353318

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test